Q4 2017 Holdings
Filed 2018-02-14 | 161 holdings | $6.2M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2018-02-15) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Astrazeneca PLCPut | ADR | 046353958 | $26.1K | 7,511 | 0.4% |
| Sarepta Therapeutics IncCall | COM | 803607900 | $50.2K | 9,023 | 0.8% |
| Astrazeneca PLCCall | ADR | 046353908 | $51.9K | 14,946 | 0.8% |
| Spdr S&P 500Call | TR | 78462F903 | $53.6K | 3,000 | 0.9% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $57.1K | 931,807 | 0.9% |
| Ishares Russell 2000Call | ETF | 464287905 | $64.1K | 4,205 | 1.0% |
| Bluebird BIO IncCall | COM | 09609G900 | $75.7K | 4,250 | 1.2% |
| Merck & Co IncCall | COM | 58933Y905 | $102.5K | 18,222 | 1.7% |
| Bristol Myers Squibb CoPut | COM | 110122958 | $212.5K | 34,682 | 3.4% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $2.4M | 19,250 | 39.4% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $2.7M | 27,559 | 43.0% |